Atria Investments’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.14M Sell
7,516
-11,405
-60% -$1.73M 0.01% 962
2025
Q1
$2.85M Buy
18,921
+1,052
+6% +$158K 0.04% 563
2024
Q4
$3.3M Sell
17,869
-2,480
-12% -$458K 0.04% 495
2024
Q3
$4.01M Sell
20,349
-756
-4% -$149K 0.05% 423
2024
Q2
$4.36M Buy
21,105
+3,603
+21% +$744K 0.06% 377
2024
Q1
$4.74M Buy
17,502
+2,873
+20% +$778K 0.07% 351
2023
Q4
$3.46M Buy
14,629
+1,688
+13% +$399K 0.05% 400
2023
Q3
$2.54M Buy
12,941
+902
+7% +$177K 0.05% 481
2023
Q2
$2.53M Buy
12,039
+689
+6% +$145K 0.05% 478
2023
Q1
$2.29M Buy
11,350
+168
+2% +$33.9K 0.04% 496
2022
Q4
$2.44M Buy
11,182
+2,338
+26% +$509K 0.05% 443
2022
Q3
$1.74M Sell
8,844
-1,504
-15% -$296K 0.04% 530
2022
Q2
$2.21M Sell
10,348
-287
-3% -$61.4K 0.05% 467
2022
Q1
$3.02M Sell
10,635
-1,975
-16% -$561K 0.05% 424
2021
Q4
$4.75M Sell
12,610
-205
-2% -$77.2K 0.08% 292
2021
Q3
$5.29M Buy
12,815
+713
+6% +$294K 0.1% 233
2021
Q2
$4.48M Buy
12,102
+2,896
+31% +$1.07M 0.09% 262
2021
Q1
$2.67M Buy
9,206
+486
+6% +$141K 0.06% 370
2020
Q4
$2.18M Buy
8,720
+159
+2% +$39.7K 0.05% 398
2020
Q3
$1.94M Buy
8,561
+197
+2% +$44.6K 0.06% 351
2020
Q2
$1.46M Buy
+8,364
New +$1.46M 0.05% 389
2020
Q1
Sell
-6,036
Closed -$922K 670
2019
Q4
$922K Buy
6,036
+2,143
+55% +$327K 0.03% 563
2019
Q3
$515K Sell
3,893
-523
-12% -$69.2K 0.02% 569
2019
Q2
$564K Buy
4,416
+1,176
+36% +$150K 0.02% 547
2019
Q1
$471K Sell
3,240
-2,338
-42% -$340K 0.02% 550
2018
Q4
$631K Sell
5,578
-198
-3% -$22.4K 0.03% 423
2018
Q3
$777K Buy
5,776
+1,839
+47% +$247K 0.03% 462
2018
Q2
$442K Buy
3,937
+215
+6% +$24.1K 0.02% 608
2018
Q1
$397K Buy
3,722
+589
+19% +$62.8K 0.02% 587
2017
Q4
$343K Sell
3,133
-1,382
-31% -$151K 0.02% 599
2017
Q3
$488K Buy
+4,515
New +$488K 0.03% 462